Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical...
-
Upload
katelynn-kanney -
Category
Documents
-
view
220 -
download
1
Transcript of Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical...
![Page 1: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/1.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Introduction to Clinical Pharmacology
Chapter 10Antitubercular Drugs
Introduction to Clinical Pharmacology
Chapter 10Antitubercular Drugs
![Page 2: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/2.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antitubercular Drugs: Actions and UsesAntitubercular Drugs: Actions and Uses
• Bacteriostatic against the M. tuberculosis bacillus: Act to inhibit bacterial cell wall synthesis, which slows the multiplication rate of the bacteria
• Used with other drugs to treat active TB—exception isoniazid (INH)
![Page 3: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/3.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antitubercular Drugs: TreatmentAntitubercular Drugs: Treatment• Standard treatment:
– Initial phase
– Continuing phase
• Retreatment:
– Includes the use of four or more antitubercular drugs
– Treatment is individualized based on the susceptibility of the microorganism
![Page 4: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/4.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Ethambutol: Adverse ReactionsEthambutol: Adverse Reactions
• Generalized reactions:
– Dermatitis and pruritus; joint pain; anorexia; nausea and/or vomiting
• More severe reactions:
– Anaphylactoid reactions; optic neuritis
![Page 5: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/5.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Ethambutol: Contraindications and PrecautionsEthambutol: Contraindications and Precautions
• Contraindicated in patients:
– With a history of hypersensitivity to the drug; younger than 13 years
• Used cautiously in patients:
– During pregnancy (pregnancy category B); with hepatic or renal impairment; with diabetic retinopathy or cataracts
![Page 6: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/6.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Isoniazid: Adverse ReactionsIsoniazid: Adverse Reactions• Generalized reactions:
– Nausea and/or vomiting; epigastric distress; fever; skin eruptions; hematologic changes; jaundice; hypersensitivity
• Toxicity:
– Peripheral neuropathy
– Severe, and sometimes fatal
![Page 7: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/7.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Isoniazid: Contraindications and PrecautionsIsoniazid: Contraindications and Precautions• Contraindicated in patients:
– With a history of hypersensitivity to the drug
• Used cautiously in patients:
– During pregnancy (pregnancy category C) or lactation and in patients with hepatic and renal impairment
![Page 8: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/8.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Isoniazid: InteractionsIsoniazid: InteractionsInteractant drug Effect of interaction
Aluminum salts Reduced absorption of isoniazid
Anticoagulants Increased risk for bleeding
Phenytoin (Dilantin) Increased serum levels of phenytoin
Alcohol (in beverages) Higher incidence of drug-related hepatitis
![Page 9: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/9.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pyrazinamide: Adverse ReactionsPyrazinamide: Adverse Reactions
• Generalized reactions:
– Nausea and/or vomiting; diarrhea; myalgia; rashes
• Hepatotoxicity:
– Symptoms may range from none (except for slightly abnormal hepatic function test results) to a more severe reaction such as jaundice
![Page 10: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/10.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pyrazinamide: Contraindications, Precautions, and InteractionsPyrazinamide: Contraindications, Precautions, and Interactions• Contraindicated in patients with known
hypersensitivity to the drug; acute gout; severe hepatic damage
• Use cautiously in patients during pregnancy and lactation; with hepatic and renal impairment; with HIV; with diabetes mellitus
• Interaction: With allopurinol, colchicine, and/or probenecid—its effectiveness decreases
![Page 11: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/11.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Rifampin: Adverse ReactionsRifampin: Adverse Reactions
• Generalized reactions:
– Nausea, vomiting
– Epigastric distress, heartburn, fatigue
– Vertigo, rash
– Reddish-orange discoloration of body fluids
– Hematologic changes, renal insufficiency
![Page 12: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/12.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Rifampin: Contraindications, Precautions, and InteractionsRifampin: Contraindications, Precautions, and Interactions• Contraindicated in patients with known
hypersensitivity to the drug
• Used cautiously in patients with renal or hearing impairment; during pregnancy and lactation
• Interactions: With digoxin; oral contraceptives; isoniazid; oral anticoagulants; oral hypoglycemics; chloramphenicol; phenytoin; verapamil
![Page 13: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/13.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: AssessmentNursing Process: Assessment
• Preadministration assessment:
– Assess a family history and a history of contacts, if the patient has active TB
• Ongoing assessment:
– Observe the patient daily for the appearance of adverse reactions and report if found
– Carefully monitor vital signs daily
![Page 14: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/14.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Nursing DiagnosesNursing Process: Nursing Diagnoses
• Acute Pain
• Imbalanced Nutrition: Less Than Body Requirements
• Risk of Ineffective Self-Health Management
![Page 15: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/15.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: PlanningNursing Process: Planning
• The expected outcome includes an optimal response to therapy:
– Management of adverse drug reactions
– Understanding of and compliance with the prescribed treatment regimen
![Page 16: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/16.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: ImplementationNursing Process: Implementation
• Promoting an optimal response to therapy:
– Allow time for the patient and family members to ask questions
•Refer the patient to other health care workers, such as a social service worker or a dietitian
![Page 17: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/17.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Implementation (cont.)Nursing Process: Implementation (cont.)
• Monitoring and managing patients’ needs:
– Acute Pain: Frequent parenteral injections
•Be careful to rotate the injection sites
•Inspect previous injection sites for signs of swelling, redness, and tenderness
•Notify if necessary
![Page 18: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/18.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Implementation (cont.)Nursing Process: Implementation (cont.)
• Monitoring and managing patients’ needs (cont.):
– Imbalanced Nutrition: Less Than Body Requirements
•Be aware of dosing regimen with/without food for ethambutol, pyrazinamide; monitor for gastric upset; use alternative dosing regimen or combination drugs; explain coloration of bodily fluids
![Page 19: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/19.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Implementation (cont.)Nursing Process: Implementation (cont.)
• Monitoring and managing patients’ needs (cont.):
– Ineffective Therapeutic Regimen Management:
•To help prevent the problem of noncompliance—directly observed therapy (DOT)
![Page 20: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/20.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: Implementation (cont.)Nursing Process: Implementation (cont.)
• Educating the patient and family: Careful patient and family education and close medical supervision are necessary
– Explain that short-term therapy is of no value in treating this disease
– Remain alert for statements made by the patient or family that may indicate future noncompliance with the drug regimen
![Page 21: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/21.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Process: EvaluationNursing Process: Evaluation
• The therapeutic effect is achieved
• Adverse reactions are identified, reported, and managed successfully
• Pain or discomfort following IM or IV administration is relieved or eliminated
• Patient and family demonstrate understanding of the drug regimen
• Patient complies with the prescribed drug regimen
![Page 22: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/22.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
• Is the following statement true or false?
• The nursing diagnosis of Ineffective Self-Health Management may be especially important with patients considering the short-term therapy required to treat TB.
![Page 23: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/23.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
• False
• The nursing diagnosis of Ineffective Self-Health Management may be especially important with patients considering the long-term therapy required to treat TB.
![Page 24: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/24.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
• Is the following statement true or false?
• Directly observed therapy (DOT) involves a patient being directly watched by a health care provider when taking the antitubercular drugs.
![Page 25: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/25.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
• True
• Directly observed therapy (DOT) involves a patient being directly watched by a health care provider when taking the antitubercular drugs.
![Page 26: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/26.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
• How long does a patient have to be on preventive therapy for exposure to tuberculosis?
• A. 1 month
• B. 2 months
• C. 4 months
• D. 6 months to 1 year
![Page 27: Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 10 Antitubercular Drugs.](https://reader035.fdocuments.in/reader035/viewer/2022062417/551bdc03550346b4588b5aef/html5/thumbnails/27.jpg)
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
• D
• Preventive therapy (prophylaxis for those exposed but who do not have active disease) involves one drug taken for 6 months to 1 year.